Compare CYD & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYD | TNDM |
|---|---|---|
| Founded | 1951 | 2006 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 1998 | 2013 |
| Metric | CYD | TNDM |
|---|---|---|
| Price | $44.15 | $20.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 19 |
| Target Price | ★ $60.00 | $28.00 |
| AVG Volume (30 Days) | 97.7K | ★ 1.5M |
| Earning Date | 02-24-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.21% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,014,736,000.00 |
| Revenue This Year | $15.11 | $8.11 |
| Revenue Next Year | $8.67 | $11.85 |
| P/E Ratio | $32.71 | ★ N/A |
| Revenue Growth | N/A | ★ 7.93 |
| 52 Week Low | $14.50 | $10.00 |
| 52 Week High | $56.55 | $29.65 |
| Indicator | CYD | TNDM |
|---|---|---|
| Relative Strength Index (RSI) | 57.93 | 46.49 |
| Support Level | $35.24 | $19.70 |
| Resistance Level | $45.94 | $21.54 |
| Average True Range (ATR) | 1.93 | 1.16 |
| MACD | 0.59 | 0.15 |
| Stochastic Oscillator | 71.59 | 54.25 |
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.